Aarvik Therapeutics, Inc. announced it raised $8.33 Million in an initial filing from an offering of $8.33 Million
Sep 02, 2021•about 4 years ago
Amount Raised
$8.33 Million
HaywardBiotechnologyHealthcare
Company Information
Company
Aarvik Therapeutics
Location
31363 Medallion Dr
Hayward, California, United States
About
Aarvik Therapeutics is pursuing exciting, novel molecules with an improved therapeutic index for several oncology targets by combining a novel modular antibody platform with multiple target mechanisms.